Suppression of cortical epileptic afterdischarges in developing rats by anticonvulsants increasing GABAergic inhibition

Epilepsy Research
R PolásekJ Vorlicek

Abstract

The anticonvulsant action of three drugs facilitating GABAergic inhibition by different mechanisms (valproate, phenobarbital and progabide) was studied in 229 young rats (12, 18 and 25 days old) with implanted electrodes. Epileptic afterdischarges (ADs) elicited by electrical stimulation of the sensorimotor cortex were used as a model. All three drugs were able to suppress ADs, even the lowest doses used blocked the prolongation seen with repeated stimulations under control conditions. In addition to these general effects, some differences among the three drugs were observed: phenobarbital (10, 20, and 40 mg/kg i.p.) exhibited marked anticonvulsant action in all three age groups whereas valproate (200 and 400 mg/kg i.p.) was somewhat less effective in the youngest rats studied than in the two older groups. Progabide exhibited an effect similar to valproate when a higher dose (150 mg/kg i.p.) was taken into account, but the lower dose (75 mg/kg i.p.) was most efficient in 12 day old rat pups. Our data support the possibility that cortical ADs represent a model of human myoclonic seizures. In addition, they suggest an uneven development of individual components of the GABAergic inhibitory system.

References

Jan 1, 1979·Developmental Psychobiology·D StaudacherováS Trojan
Oct 1, 1992·Epilepsy Research·L StankováP Mares
Jul 4, 1992·BMJ : British Medical Journal·P L Timmings, A Richens
Oct 1, 1988·Clinical Neuropharmacology·O MecarelliG F Ricci
Mar 1, 1972·Electroencephalography and Clinical Neurophysiology·R J Racine
Jan 1, 1984·Epilepsia·D Johnston
Jan 1, 1984·Journal of Neural Transmission·T HednerP Lundborg
Jul 1, 1981·Brain Research·P T Wong, E G McGeer
Jan 1, 1995·European Journal of Clinical Pharmacology·Y SuzukiS Okada
Jan 1, 1993·Epilepsia·R L Macdonald, K M Kelly
Nov 1, 1993·Annals of Neurology·A R Brooks-Kayal, D B Pritchett
Sep 1, 1993·The Journal of Pharmacy and Pharmacology·H KubováJ Vorlícek
Jul 1, 1993·Brain Research. Molecular Brain Research·V Luntz-LeybmanA Rotter
Apr 1, 1996·Epilepsia·H KubovaJ Vorlicek
Feb 1, 1995·Nihon rinsho. Japanese journal of clinical medicine·H KawasakiY Gomita

❮ Previous
Next ❯

Citations

Aug 20, 1997·European Journal of Pharmacology·H KubováP Mares
Dec 14, 1999·European Journal of Pharmacology·A SabauA Draguhn
Apr 21, 1999·Brain Research. Brain Research Reviews·A K Mehta, M K Ticku
Apr 3, 2010·Pharmacological Reports : PR·Marie PometlováPavel Mares
Apr 23, 2004·Expert Opinion on Pharmacotherapy·Asla Pitkänen, Hana Kubova

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.